Results 261 to 270 of about 101,655 (293)

Plasminogen polymorphism in swine

Comparative Biochemistry and Physiology Part B: Comparative Biochemistry, 1989
1. Plasminogen polymorphism in swine (Sus scrofa) plasma was demonstrated by immunoblotting. 2. Eleven plasminogen phenotypic patterns, including a null pattern, were detected. 3. The null pattern was associated with extremely low plasma triglyceride and increased unesterified cholesterol levels. 4.
Walter J. McConathy, Walter J. McConathy, Zeilko Reiner, Zeilko Reiner, Judith Hasler-Rapacz, Judith Hasler-Rapacz, Jan Rapacz, Jan Rapacz, Rapacz Jan, Rapacz Jan, Shui-Qing Ye, Shui-Qing Ye   +11 more
openaire   +3 more sources

Plasminogen activator / plasminogen activator inhibitors in ovarian physiology

Frontiers in Bioscience, 2004
The target extracellular matrix (ECM) degradation generated by plasminogen activator (PA) and regulated by plasminogen activator inhibitor (PAI) is an event that affects a wide variety of physiological and pathological processes in the ovary. Studies carried out over the past 25 years in a number of laboratories have elucidated some of the biochemical ...
openaire   +3 more sources

Studies on the kinetics of plasminogen activation by tissue plasminogen activator

Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
The steady-state rate of plasminogen activation by tissue plasminogen activator has been determined at various plasminogen concentrations. A plasmin substrate method similar to that presented by Christensen and Müllertz (Biochim. Biophys. Acta 480 (1977) 257-281) was used.
openaire   +3 more sources

Plasminogen and Tissue Plasminogen Activator Interact with Antithrombin III

Thrombosis Research, 2000
Human antithrombin III was demonstrated to bind plasminogen specifically in a time and concentration-dependent manner. The above binding was also confirmed using ligand western blot assays. The interaction of plasminogen was significantly (>90%) inhibited by lysine, indicating the involvement of kringles in binding antithrombin III.
openaire   +3 more sources

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Journal of the American Medical Association (JAMA), 1995
W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, R. von Kummer, G. Boysen, E. Bluhmki, G. Höxter, M. Mahagne   +9 more
semanticscholar   +1 more source

Zymographic Evaluation of Plasminogen Activators and Plasminogen Activator Inhibitors

2004
Publisher Summary The plasminogen activator/plasminogen activator inhibitor (PA/PAI) system is of considerable fundamental importance in elucidating the biochemical mechanisms of many physiological and patho-physiological processes. Although many techniques are available to assess the PA/PAI system, including ELISA and molecular assays, fibrin ...
openaire   +3 more sources

Thrombotic Manifestations in Plasminogen Deficiency and in Plasminogen Abnormalities

Thrombosis and Haemostasis, 1988
GIROLAMI, ANTONIO, Lazzaro A, SIMIONI, PAOLO   +2 more
openaire   +4 more sources

The Plasminogen (Fibrinolytic) System

Thrombosis and Haemostasis, 1999
IntroductionThe plasminogen (fibrinolytic) system (Fig. 1) comprises an inactive proenzyme, plasminogen, that can be converted to the active enzyme, plasmin. Plasmin degrades fibrin and activates matrix metalloproteinases (MMPs) that, in turn, degrade the extracellular matrix (ECM).1-3 Two physiological plasminogen activators (PAs) have been identified:
openaire   +3 more sources

Plasminogen activators, tissue degradation, and cancer.

Advances in Cancer Research, 1985
K. Danø, P. Andreasen, J. Grøndahl-Hansen, Peter Marcus Kristensen, L. Nielsen, L. Skriver   +5 more
semanticscholar   +1 more source

Interaction of Plasminogen Activators and Inhibitors with Plasminogen and Fibrin

Seminars in Thrombosis and Hemostasis, 1982
D. Collen, H. R. Lijnen
openaire   +3 more sources